Sharing a home with a pet appeared to act as a buffer against psychological stress during lockdown, a new survey shows.
Sep 25, 2020
0
647
There's "promising evidence" that osteopathy, the physical manipulation of the body's tissues and bones, may relieve the pain associated with musculoskeletal conditions, finds a review of the available clinical evidence, ...
Apr 12, 2022
0
158
Tagrisso (osimertinib) received approval as an adjuvant treatment for patients with non-small cell lung cancer with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, the U.S. Food and Drug ...
Dec 23, 2020
0
5
The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial. The drug is designed ...
Jun 4, 2021
0
41
A medication for high cholesterol can drastically cut "forever chemicals" (PFAS)—associated with an increased risk of cancer and banned in Europe—in the blood, researchers said Thursday.
Feb 29, 2024
0
55
Adjuvants—ingredients that help boost the immune response in vaccines—have been used in vaccines for decades. But inducing a stronger immune response can result in more unwanted side effects, like swelling at the injection ...
Apr 5, 2023
0
35
You may think that artificial sweeteners can help you lose some weight, but a new study finds they are no good for your gut's microbiome.
Jan 3, 2024
0
33
Researchers at the University of York have developed a new way to safely remove a blood-thinning drug used during surgery that can lead to harmful side-effects in recovering patients.
Jul 4, 2019
0
2
Scientists at Duke-NUS Medical School have identified a gene that controls the behavior of a specific type of cardiac macrophage responsible for excessive scarring during the early phases of common heart diseases or cardiomyopathies. ...
Dec 9, 2022
0
77
Lung cancer is the deadliest form of cancer, accounting for an estimated 1.8 million deaths worldwide.
Jul 14, 2022
0
64
